MD Acumen · MRCGP SCA course · free practice resources
MRCGP SCA course · Station 8
Station 8 · Asthma
A 19-year-old student has used three blue inhalers in two months, does not take the brown one, and has just come out of the emergency department.
Reviewed and kept current
Video consultation · Long-term condition · Prescribing · Under 19 · 12-minute case · 3 min reading · Last editorial review: 11 October 2026 · Next scheduled refresh: 11 April 2027 · Clinical content signed by Course Director, 11 October 2026.
Candidate instructions
Read this as you would outside the room
Read the brief as you would in the examination (RCGP: twelve consultations with simulated patients, each lasting twelve minutes, with 3 minutes' reading at the start of each). There is no reference material. Everything below the brief is folded until the consultation is over.
| Information | |
|---|---|
| Frame | You have 3 minutes to read, then 12 minutes. Video consultation. Everything below this brief is folded away until the consultation is over. |
| Your role | GP registrar at a town practice, holding the afternoon's video list. |
| Patient | Jamie Whitlock, 19. |
| Reason for consultation | “Inhaler.” A repeat request refused by the pharmacist; the emergency department has asked for review within two days. |
| Format | Video. He is in his bedroom at his parents' house; you can see his face and hear his breathing. You cannot examine him; you may ask what he can do and show you, including his inhaler technique and a peak flow if he has a meter. |
Information available
The records extract, printed as it appears.
| Problem list | Asthma since childhood. Hay fever. Eczema, mild. Smoking status: vapes. |
| Medication | Salbutamol 100 micrograms inhaler: three issued in 8 weeks. Beclometasone 200 micrograms, two puffs twice daily: last issued 9 months ago. Allergies: none recorded. |
| Emergency department letter, 5 days ago | Acute asthma. Peak flow 55% of predicted on arrival; oxygen saturation 94%. Nebulised salbutamol and ipratropium; prednisolone 40 mg for 5 days. Discharged. GP review within 2 days. |
| Asthma review | None for 18 months. No personalised action plan on record. Peak flow meter: not recorded. |
| Previous | Two emergency attendances as a teenager. One course of oral steroids last winter from a walk-in centre. |
Your task
•
Assess his asthma and the attack.
•
Reach a working assessment of his control and the risk, and explain it.
•
Agree the changes to his treatment and a plan for the next attack.
•
Address his concerns.
Folded away
For the role player and the observer
Open these after the consultation, or during it if you are observing. The role-player script and every marking section are public (D-76): this is practice material, not an examination.
1 · Role-player script — opening line, story, ICE, hidden facts and triggers (examination findings last)
Candidates: do not open until you have consulted.
Persona and manner
- Jamie Whitlock, 19, a first-year university student home for the summer; easy-going, a bit sheepish about the hospital visit; you want this over quickly; phone in hand; you answer honestly when asked directly.
- You believe the blue inhaler is the real treatment and the brown one is for when it is bad, which it never is, “until it is”.
Opening line (verbatim)
- “Hi — I just need my blue inhaler, the pharmacy wouldn't give me one. I was in A&E last week but I'm fine now, honestly, they gave me steroids and I'm all good.”
The story
- “I've been wheezy most days over the summer. It's the pollen. I use the blue a few times a day, more at night.”
- “The A&E thing was a bad night. I couldn't finish sentences. My friend drove me in. It was scary at the time.”
- “The steroid tablets finished two days ago and I feel back to normal.”
- If asked about nights: waking with wheeze three or four nights a week before the attack; still one or two nights now.
- If asked how much blue: eight to ten puffs a day at worst, “a couple” on good days; three canisters in two months.
- If asked about the brown one: “I stopped it because it does nothing you can feel, and I heard steroids are bad for you.” You use it for a few days when you are bad.
- You vape quite a lot, nicotine; a few cigarettes at festivals; cannabis occasionally at parties.
- Two hospital visits as a teenager; one course of steroid tablets last winter from a walk-in centre. You have never been shown how to use an inhaler; no spacer.
- Triggers: pollen, dust in the student flat, cold air, running for the bus. A cat at your girlfriend's house. Hay fever: cetirizine “sometimes”.
- No peak flow meter at home. If asked what you would do if it got bad again: “Go to A&E again, I suppose.”
Ideas, concerns and expectations
- Idea: “My asthma's mild. It's just the summer.”
- Concern: None volunteered. If asked what worried you about the attack: “I couldn't breathe, I thought I was going to pass out.” Then shrug it off.
- Expectation: A blue inhaler, and to go.
Impact
- Life: you live with your parents in the summer and in a student flat in term time; exams in January; shifts in a bar.
- Activity: you avoid running for the bus; the bar shifts leave you wheezy by the end.
- Driving: not relevant. Money: a new inhaler is a prescription charge you would rather not pay twice.
Red flags
- Present: A recent attack with a peak flow of 55% and a saturation of 94%, three salbutamol canisters in two months, no inhaled steroid for months, night waking most nights, no action plan, no review for 18 months, two earlier emergency attendances.
- Absent: No attack today: you speak in full sentences; no chest pain; no fever; no cough productive of discoloured sputum.
- Absent: No previous intensive care admission or ventilation.
Hidden facts and their triggers
- The night waking three or four nights a week — released only if asked about nights or sleep
- The puff count: eight to ten a day at worst — released only if asked how many puffs on a bad day, rather than “how often”
- The two earlier hospital visits and the steroid course last winter — released only if asked about previous attacks, or if the doctor reads the record and asks
- “I heard steroids are bad for you” — released only if the brown inhaler is raised
- “I thought I was going to pass out” — released only if asked what the attack was like, or what worried you
Behaviour
- Minute 1: “The pharmacy wouldn't give me one.” Indignant.
- Minute 4, when the brown inhaler is raised: “I heard steroids are bad for you.”
- Minute 7, if asked about the attack: “I thought I was going to pass out.” Quiet.
- If the doctor treats this as uncontrolled asthma after a serious attack, explains the difference between a reliever and a preventer in your terms, offers one inhaler that treats and prevents (or a daily preventer with the blue kept for emergencies), checks and teaches your technique, gives a written plan with peak flow, deals with the vaping and the cat, arranges follow-up in two to four weeks, and tells you exactly when to call 999: surprised. “So I can bin the blue one?” Engage.
- If the doctor issues salbutamol and tells you to take your brown one: “Yeah, OK.” Leave.
- If the doctor lectures about steroids being safe without hearing your belief: “That's what they all say.”
- If jargon is used (MART, ICS, AIR): “What's that?”
Examination findings, if the candidate states what they would examine and why
- Video: you talk in full sentences; if asked to count your breathing it is 16 a minute; no audible wheeze at rest.
- If asked to show your inhaler technique with the blue inhaler: you fire it before you breathe in and do not hold your breath. No spacer at home.
- If the candidate states what they would examine in person and why: at the nurse's visit saturation 97%, scattered expiratory wheeze, peak flow 380 L/min against a predicted 590 (about 65%). No meter at home today.
2 · Examiner mark sheet — generic SCA scheme plus the key facts for this case
Domain grades — with the key facts that earn a clear pass at this station
| Domain (RCGP wording) · key facts for this case | CF (0) | F (1) | P (2) | CP (3) | Score |
|---|---|---|---|---|---|
1 · Data gathering and diagnosis
| ☐ | ☐ | ☐ | ☐ | /3 |
2 · Clinical management and medical complexity (×1.5)
| ☐ (0) | ☐ (1.5) | ☐ (3) | ☐ (4.5) | /4.5 |
3 · Relating to others
| ☐ | ☐ | ☐ | ☐ | /3 |
| Case total | /10.5 |
Global rating (recorded, not added to the total): ☐ Fail ☐ Bare Fail ☐ Bare Pass ☐ Pass
The domain grades (RCGP descriptors): CP clear pass — above the standard of a newly qualified, independent GP · P pass — sufficiently demonstrated at the standard · F fail — insufficiently demonstrated at the standard · CF clear fail — clearly demonstrated below the standard.
The RCGP grades each domain CF, F, P or CP and weights clinical management and medical complexity against the other two domains; the examination's maximum is 126 over twelve cases, which is 10.5 per case. The RCGP does not publish the mark each grade carries. MD Acumen's training sheet uses CF 0 · F 1 · P 2 · CP 3, with clinical management weighted ×1.5 (0 · 1.5 · 3 · 4.5), so that a case is marked out of 10.5 and a twelve-case circuit out of 126. A P in all three domains is 7.0; MD Acumen treats that line as the training standard for a case. The examination's pass mark is set by borderline regression for each diet and is published in the RCGP's diet summary reports; it is not a fixed fraction of 126.
Weighting rationale, in the RCGP's words: “To reflect the capability coverage within the clinical management and medical complexity domain this is weighted in comparison to the other two domains.”
3 · Expanded station standard — what earns a clear pass, pass, fail and clear fail here
Written to the standard of a newly qualified independent GP; the clear-pass row describes practice above that standard. It is a debriefing aid, not a checklist: the grade is a judgement that the essentials, the italic key facts on the mark sheet, were done well, at the patient's pace and in plain language. MD Acumen training standard; the RCGP does not publish case mark sheets.
| Grade | Data gathering and diagnosis | Clinical management and medical complexity | Relating to others |
|---|---|---|---|
| CP | Names the risk aloud in the first three minutes: three canisters in eight weeks, a recent serious attack and no preventer are the markers found in asthma deaths. Asks the questions that quantify control (puffs on a bad day, nights, limitation) rather than “how is it?”. Watches him use the inhaler. Asks what the attack was like and what he thought would happen. Asks about the cat, the flat, vaping and cannabis without changing tone. | Replaces the reliever-alone pattern with a steroid-formoterol inhaler used as needed, stepping to maintenance and reliever if control is poor, explains the mechanism in one sentence he can repeat, teaches the technique and gives a spacer if a pressurised device is used, writes the action plan with peak flow zones and the 999 triggers, treats the hay fever, offers vaping cessation, books the review and the annual review. Involves the asthma nurse and the university health service. | Answers the steroid belief with specifics: inhaled dose, local effect, the harm of the alternative, without reassurance for its own sake. Uses his own words about the attack to anchor the plan without frightening him. Asks what he wants to be able to do (run for the bus, the bar shifts) and builds the plan to fit one inhaler and term-time life. Non-judgemental about the vaping and the hospital visit. Checks understanding by asking him to explain his own plan. |
| P | Assesses control: reliever use, night symptoms, limitation, exacerbations (the attendances and steroid courses). Explores preventer adherence and beliefs. Asks about triggers, vaping and cannabis. Checks inhaler technique and device. Uses the emergency department letter and the prescribing record. Working assessment: poorly controlled asthma with reliever over-reliance after a serious attack. | Steps up to an inhaled steroid-containing regimen per current guidance (a low-dose steroid-formoterol inhaler as the anti-inflammatory reliever, or as maintenance and reliever), replacing salbutamol alone; teaches the technique and chooses the device with him; a written action plan with peak flow; hay fever treated; vaping cessation offered; influenza vaccination advised. Follow-up in two to four weeks and an annual review; safety-net: 999 if unable to speak in sentences, the reliever not lasting four hours, or blue lips. | Non-judgemental about the emergency visit and the vaping. Addresses the steroid belief with a specific, honest answer about the inhaled dose and its local effect. Adapts the explanation to a 19-year-old, avoids the labels for the regimen, and checks understanding by asking him to explain his own plan and when he would call 999. Shares the choice of inhaler and makes the plan fit term-time life. |
| F | Reissues salbutamol without assessing control. Does not explore why the preventer was stopped. Ignores the emergency attendance or the three canisters in the record. Does not watch him use the inhaler. Does not ask about nights, puffs or the previous attacks. | Salbutamol alone, with an instruction to take the brown one. No action plan. No technique check and no spacer. No follow-up after a serious attack, or a review left for him to book. Hay fever and vaping unaddressed. The 999 triggers vague or absent, so that he would do what he did last time: wait, and then go to the emergency department. | Scolds him for the vaping or the hospital visit. Uses MART, ICS and AIR without explaining them. Lectures that steroids are safe without hearing “I heard steroids are bad for you”. Talks about him as if to an absent parent. Does not ask what he wants to be able to do. |
| CF | No assessment of control at all; the attack treated as finished because the steroid course is over; the record not read; the belief about steroids never heard. Or a history so disorganised that no working assessment is stated at the end of twelve minutes. | Unsafe: another salbutamol inhaler issued to a 19-year-old five days after an attack with a peak flow of 55%, no inhaled steroid, no action plan and no review; or a plan that leaves him with the same pattern and the same triggers. He leaves as likely to be back in the emergency department as when he arrived. | Dismissive, scolding or patronising; argues about steroids without listening to the belief; jargon throughout with no check of understanding; ends without any check that he knows what to do in the next attack. No partnership: the plan is one he will not follow, and the doctor has not asked what he wants to be able to do or what the attack was like for him. |
Where candidates lose this station
- Asking how often he uses the blue inhaler and accepting “a few times a day”, without the puff count or the night waking (statement D1)
- Issuing salbutamol with an instruction to take the brown one, and no action plan, no technique check and no review after a serious attack (statement C8)
- Answering “I heard steroids are bad for you” with reassurance rather than a specific explanation, so that he hears “that's what they all say” (statement R4)
What the examiner is listening for in the last four minutes
By 8:00 the working assessment should have been stated: uncontrolled asthma with reliever over-reliance after a serious attack. The examiner is listening for: the new regimen explained in a sentence he can repeat (one inhaler that treats and prevents); the technique taught; the written plan with peak flow zones; the 999 triggers in his words (cannot speak in sentences, the reliever not lasting four hours, blue lips); the hay fever and the vaping addressed; the review in two to four weeks; and his own explanation of what he will do next time.
4 · RCGP feedback statements — where underperformance was identified — with case-specific examples
The ten statements below are postulated: the feedback an examiner would most likely attach at this station, chosen from the RCGP's standardised list of 26 feedback statements that applies to every SCA case and spans the three marking domains (Data Gathering and Diagnosis; Clinical Management and Medical Complexity; Relating to Others). They are a prediction from the case content, its complexity and the marks that matter, not an examiner's record: any statement on the full list can be attached to any case, and feedback plays no part in the mark. Record the statements that applied in the practice log.
| RCGP feedback statement (postulated top ten) | Underperformance it signals (generic) | Station-specific example |
|---|---|---|
| D1 · Data gathering was insufficient to enable safe assessment of the condition/situation Data gathering and diagnosis · Data gathering and interpretation | History too thin to decide safely: the presenting problem not characterised, the essential negatives not asked. |
|
| D2 · Existing information about the case was insufficiently utilised Data gathering and diagnosis · Data gathering and interpretation; Organisation, management and leadership | The records, results or the referral note not read or not used; questions asked that the notes already answer. |
|
| D5 · Ineffective approach or prioritisation in data gathering, when presented with multiple or complex problems Data gathering and diagnosis · Managing medical complexity | With several problems on the table, none is prioritised; time spent on the least important. |
|
| D6 · The implications of relevant findings identified during the data gathering were insufficiently recognised or understood Data gathering and diagnosis · Data gathering and interpretation | A finding or result is elicited but its meaning is not recognised or not followed up. |
|
| C2 · The management plan relating to prescribing of medication was inappropriate or not reflective of current practice Clinical management and medical complexity · Clinical management | A drug started, continued or stopped against current guidance, or without the checks it needs. |
|
| C5 · The plan relating to the medical management of risk was inadequate or inappropriate Clinical management and medical complexity · Clinical management; Organisation, management and leadership | Clinical risk left unmanaged: no plan for the thing that could go wrong, or the risk not weighed. |
|
| C8 · Inappropriate or inadequate arrangements for follow-up, continuity and/or safety netting Clinical management and medical complexity · Clinical management | No follow-up, continuity or safety-net, or one too vague to act on. |
|
| R2 · The person's agenda, health beliefs and/or preferences were insufficiently explored Relating to others · Communication and consultation skills; Practising holistically, promoting health and safeguarding | What the person thinks is wrong, fears, or wants is not asked, or not used in the plan. |
|
| R4 · Explanations were inadequately shared or adapted for the person's needs Relating to others · Communication and consultation skills | Explanation in jargon, at the wrong pace, or not adapted to the person's level and concerns. |
|
| R8 · Teamwork and/or understanding of others' roles was insufficiently recognised or responded to Relating to others · Working with colleagues and in teams | Colleagues' roles not understood; the team not used; the handover not made. |
|
The full list of 26 statements, with the generic meaning of each, is on the exam and the mark scheme.
5 · Examiner points of fact and guidelines
Points of fact the examiner should have to hand
Each statement is drawn from the named guideline, in its current version, with the date it was checked. The examiner marks against these facts; the candidate is not expected to quote them.
- For people aged 12 and over with newly diagnosed asthma, or with asthma not controlled on a short-acting bronchodilator alone, offer a low-dose inhaled corticosteroid-formoterol combination inhaler used as needed (anti-inflammatory reliever); step up to low-dose maintenance and reliever therapy with the same inhaler if asthma is uncontrolled; a short-acting beta-agonist alone is not offered. NICE, BTS and SIGN — NG245 Asthma: diagnosis, monitoring and chronic asthma management, section 1.5, pharmacological treatment in people aged 12 and over, November 2024, checked 10 Oct 2026
- Offer every person with asthma a personalised written action plan that includes peak flow or symptom thresholds, when to increase treatment, when to start oral steroids and when to seek urgent help; review it at every asthma review and after every attack. NICE, BTS and SIGN — NG245 Asthma: diagnosis, monitoring and chronic asthma management, section 1.8, self-management, November 2024, checked 10 Oct 2026
- Markers of increased risk of asthma attacks and asthma death include a recent attack, three or more short-acting bronchodilator canisters in a year, poor adherence to inhaled corticosteroid, no action plan, and previous emergency attendance; anyone using three or more reliever canisters a year should be reviewed. Royal College of Physicians — Why asthma still kills: the National Review of Asthma Deaths, key findings and recommendations, 2014, checked 10 Oct 2026
- After an acute asthma attack treated in hospital, the person should be reviewed in primary care within two working days of discharge, with the trigger, the treatment, the inhaler technique and the action plan addressed. BTS and SIGN — British guideline on the management of asthma (SIGN 158), section 9, management of acute asthma: follow-up after discharge, 2019, checked 10 Oct 2026
- Check inhaler technique at every review and whenever a new device is prescribed; a spacer is used with a pressurised metered-dose inhaler; the choice of device is made with the person and only a device they can use is prescribed. NICE, BTS and SIGN — NG245 Asthma: diagnosis, monitoring and chronic asthma management, section 1.6, inhaler technique and devices, November 2024, checked 10 Oct 2026
- Allergic rhinitis that is persistent or affecting asthma control is treated with a regular non-sedating antihistamine and an intranasal corticosteroid; treating rhinitis improves asthma symptoms. NICE CKS — Allergic rhinitis, management, current online version, checked 10 Oct 2026
- Advise everyone who smokes or vapes to stop and offer support; adults who use nicotine vapes to stop smoking should be supported to stop vaping in due course; cannabis smoking worsens respiratory symptoms. NICE — NG209 Tobacco: preventing uptake, promoting quitting and treating dependence, section 1.12, stop-smoking interventions; section 1.14, nicotine-containing e-cigarettes, 2021, last updated January 2025, checked 10 Oct 2026
- At every asthma review, in addition to asking about symptoms, check time lost from work or education, how much reliever is being used (including the number of short-acting beta-agonist inhalers issued), the number of courses of oral corticosteroids, and any hospital admission or emergency attendance; consider a validated questionnaire such as the Asthma Control Questionnaire or the Asthma Control Test. Three salbutamol inhalers in eight weeks with no inhaled corticosteroid issued for nine months is uncontrolled asthma on these measures, and treatment is stepped up rather than the reliever re-issued. NICE, BTS and SIGN — NG245 Asthma: diagnosis, monitoring and chronic asthma management, section 1.4, monitoring asthma control, November 2024, checked 10 Oct 2026
- If asthma is uncontrolled on low-dose maintenance and reliever therapy, offer moderate-dose maintenance and reliever therapy with the same inhaled corticosteroid-formoterol inhaler. If it remains uncontrolled, check the fractional exhaled nitric oxide and the blood eosinophil count: if either is raised, refer to a specialist; if neither is raised, consider a trial of a leukotriene receptor antagonist or a long-acting muscarinic antagonist added to the moderate-dose regimen, reviewed for benefit before it is continued. Before any step up, confirm adherence, inhaler technique and trigger avoidance. NICE, BTS and SIGN — NG245 Asthma: diagnosis, monitoring and chronic asthma management, section 1.5, pharmacological treatment in people aged 12 and over: stepping up, November 2024, checked 10 Oct 2026
- Acute asthma in adults is graded by the worst feature present. Moderate: peak flow 50 to 75% of best or predicted and no severe feature. Acute severe: peak flow 33 to 50%, respiratory rate 25 or more a minute, heart rate 110 or more, or inability to complete a sentence in one breath. Life-threatening: peak flow below 33%, oxygen saturation below 92%, silent chest, cyanosis, poor respiratory effort, exhaustion, arrhythmia, hypotension or altered consciousness. Acute severe asthma not responding to treatment, and any life-threatening feature, needs a 999 ambulance. NICE CKS — Asthma, management: acute exacerbation, assessing severity in adults, current online version, checked 10 Oct 2026
- A person treated for an acute asthma attack takes prednisolone 40 to 50 mg once daily for at least five days or until recovery; a course of less than three weeks is stopped without tapering. The inhaled corticosteroid is continued or started during and after the course, because the oral steroid treats the attack and not the underlying inflammation; the reason for the attack and the person's adherence and technique are sought at the follow-up review. NICE CKS — Asthma, management: acute exacerbation, oral corticosteroids and follow-up, current online version, checked 10 Oct 2026
- Annual influenza vaccination is offered to people in clinical risk groups, which include asthma that requires continuous or repeated use of inhaled or systemic corticosteroids, or that has previously led to an exacerbation needing hospital admission. A 19-year-old who needs a daily inhaled corticosteroid and has had oral steroids for attacks qualifies and is offered the vaccine each autumn. Asthma is not on its own an indication for pneumococcal vaccine unless it requires continuous or frequently repeated systemic steroids. UKHSA — Immunisation against infectious disease (the Green Book), chapter 19: influenza, clinical risk groups who should receive influenza immunisation, current online edition, checked 10 Oct 2026
- The Respiratory health Topic Guide expects the GP to diagnose and manage asthma across the life course: to assess control with objective measures, to recognise acute severe and life-threatening asthma, to know the inhaler devices and their ease of use, cost, planetary impact and the patient's preference when prescribing, to teach and check technique, to provide a written self-management plan, to offer smoking cessation, and to recognise when referral to specialist care is needed. RCGP — GP curriculum: Respiratory health, Topic Guide: knowledge and skills, Being a GP, 2025 curriculum, checked 10 Oct 2026
Working references for this station
| Issuer | Document | Version | Checked |
|---|---|---|---|
| NICE, BTS and SIGN | NG245 Asthma: diagnosis, monitoring and chronic asthma management | November 2024 | 10 Oct 2026 |
| Royal College of Physicians | Why asthma still kills: the National Review of Asthma Deaths | 2014 | 10 Oct 2026 |
| BTS and SIGN | British guideline on the management of asthma (SIGN 158) | 2019 | 10 Oct 2026 |
| NICE CKS | Allergic rhinitis | current online version | 10 Oct 2026 |
| NICE | NG209 Tobacco: preventing uptake, promoting quitting and treating dependence | 2021, last updated January 2025 | 10 Oct 2026 |
| NICE CKS | Asthma | current online version | 10 Oct 2026 |
| UKHSA | Immunisation against infectious disease (the Green Book), chapter 19: influenza | current online edition | 10 Oct 2026 |
| RCGP | GP curriculum, Topic Guides: Respiratory health · Children and young people · Continuity and quality of care, safety and prescribing | Being a GP, 2025 curriculum | 10 Oct 2026 |
13 statements, 770 words. Every statement is signed by the Course Director before it is published; a station whose facts have changed since signature carries no signature line until it is signed again.
This case's topic and its signed Golden Triangle, for review after the station.
Golden Triangle
Asthma (adults)
Knowledge Green · Evidence Green · Real-world Red
Not yet at the Equinox · UK (NHS England) · as of 8 October 2026 · How the triangle works
6 · RCGP curriculum tags for this case
| RCGP curriculum (2025) | This case |
|---|---|
| Topic Guide(s) | Respiratory health · Children and young people · Continuity and quality of care, safety and prescribing |
| Core capabilities | Data gathering and interpretation · Clinical management · Communicating and consulting · Holistic practice, health promotion and safeguarding |
| SCA Clinical Experience Group(s) | Long-term condition, including cancer, multi-morbidity, and disability · Prescribing · Patient less than 19 years old |
| AKT blueprint clinical area | Respiratory medicine (broader representation) |
| Case type | long-term condition |
| Modality | video |
7 · My marks and reflection — practice log form
Record your three domain grades, your case total out of 10.5, your global rating, the RCGP feedback statements that applied, and what you will keep and change. The form is already labelled with this case and its web address; a copy of your entry is emailed to you, so your practice log builds up in your inbox and can be downloaded.
Record my marks and reflection for SCA-08
Revision link for this case: mdacumen.com/sca-station8-asthma
Independence & scope. Formative training material from MD Acumen Ltd; not a prediction of exam performance. Not affiliated with, endorsed by, or delivered on behalf of the Royal College of General Practitioners; the marking domains and feedback statements are the RCGP's published ones, and every descriptor on this page is an Acumen training tool calibrated to them. Clinical content reflects UK guidance at the date of editorial review — always check the current guideline. All patients are fictional.
Continue through the course
© 2026 MD Acumen Ltd · Registered in England and Wales · Company no. 16538952 · ICO registration ZC105897